3-D bioprinting of neural tissue for applications in cell therapy and drug screening
M Thomas, SM Willerth - Frontiers in Bioengineering and Biotechnology, 2017
Neurodegenerative diseases affect millions of individuals in North America and cost the
healthcare industry billions of dollars for treatment. Current treatment options for
degenerative diseases focus on physical rehabilitation or drug therapies which temporarily
healthcare industry billions of dollars for treatment. Current treatment options for
degenerative diseases focus on physical rehabilitation or drug therapies which temporarily
 |  |  |
3D-Bioprinting coming of age-from cells to organs
D Thomas - 2017
Over the past decade, annual spending on pharmaceutical development to treat many
endocrinological systems has increased exponentially. At the same time, in spite of these
huge sums invested, the average number of drugs being approved for human use has
endocrinological systems has increased exponentially. At the same time, in spite of these
huge sums invested, the average number of drugs being approved for human use has
| | |
[PDF] A New Aspiration-Assisted Bioprinting Method for Tissue Fabrication
B Ayan, A Povilianskas, Z Zhang, M Dey, MA Alioglu…
Methods: Mouse fibroblast cell line (3T3), mouse breast cancer cell line (4T1) and human
umbilical vein endothelial cell (HUVEC) spheroids were fabricated using U-bottom 96-well
microplate (Greiner Bio-one, Monroe, NC). Cell nuclei were then stained with NucBlue®
umbilical vein endothelial cell (HUVEC) spheroids were fabricated using U-bottom 96-well
microplate (Greiner Bio-one, Monroe, NC). Cell nuclei were then stained with NucBlue®
| | |
Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google
Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου